[Is there a relation between Alzheimer s disease and defects of mitochondrial DNA?]
Related Experiment Video
Updated: Oct 4, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
B Rodríguez Santiago1, J Casademont, V Nunes
1Hospital Duran i Reynals. Centro de Genética Médica y Molecular-IRO, L'Hospitalet de Llobregat, 08907, España.
Introduction:
Various studies have related Alzheimer s disease (AD) with mitochrondrial defects. These defects may be structural, biochemical or genetic in type. Amongst the genetic defects the rearrangement and particular mutations described in mitochondrial DNA (mtDNA) are striking.
Objective:
To study the incidence of rearrangement and 4 particular mutations in the mtDNA of patients with AD, and determine the possible differences from persons taken as controls.
Patients And Methods:
Necropsies of the cerebellum, frontal cortex and hippocampus of patients with AD and controls. We also used blood from living patients diagnosed as having EA and from controls. The samples were analysed using hybrid Southern blot with a mitochondrial probe. Particular mutations G3196A, A3397G, A4336G and G5460A/T were also analysed.
Results:
No differences were found between the patients and controls, in either brain tissue or blood on analysis using Southern. No association was found between the particular mutations analysed and the AD of our samples.
Conclusions:
The results obtained did not support the hypothesis of involvement of mitochondria in AD. Regarding rearrangement and the 4 particular mutations analysed in the mtDNA of our samples. However, this does not rule out the possible existence of other particular mutations which were not analysed and/or other mitochondrial defects which contribute to the development of AD.
Related Concept Videos
Animal Mitochondrial Genetics
Alzheimer Disease l: Introduction
Mitochondria
ATP Synthase: Mechanism
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

